84 related articles for article (PubMed ID: 2475077)
1. The importance of alpha 2-antiplasmin in the defibrination syndrome.
Wolf PL
Arch Intern Med; 1989 Aug; 149(8):1724-5. PubMed ID: 2475077
[No Abstract] [Full Text] [Related]
2. Alpha 2-plasmin inhibitor and its deficiency states.
Saito H
J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
[No Abstract] [Full Text] [Related]
3. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Williams EC
Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the fibrinolytic enzyme system.
Aoki N; Harpel PC
Semin Thromb Hemost; 1984 Jan; 10(1):24-41. PubMed ID: 6199845
[No Abstract] [Full Text] [Related]
5. [Clinical significance of alpha 2-plasmin inhibitor analysis in blood coagulation and fibrinolysis tests].
Hayashi T; Suzuki K
Nihon Rinsho; 1989 Dec; 48 Suppl():869-71. PubMed ID: 2516162
[No Abstract] [Full Text] [Related]
6. [Metabolism and distribution of I-131 fibrinogen in cancer patients with disseminated intravascular coagulation syndrome].
D'addabbo ; Macarini N; Damato V; Fanfani G; Fratello A; Ciavarella N
J Radiol Electrol Med Nucl; 1975; 56 suppl 2():658-60. PubMed ID: 1232374
[No Abstract] [Full Text] [Related]
7. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
8. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
Ikematsu S; Kato M; Kuroso K
Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
[No Abstract] [Full Text] [Related]
9. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
Kazama Y; Takahashi K; Oguma Y; Sakuragawa N
Rinsho Ketsueki; 1988 Mar; 29(3):344-8. PubMed ID: 3398266
[No Abstract] [Full Text] [Related]
10. [DIC: an application of new laboratory tests].
Ikematsu S; Hada M; Kuroso K; Arai M
Rinsho Ketsueki; 1986 Oct; 27(10):1984-91. PubMed ID: 3820618
[No Abstract] [Full Text] [Related]
11. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
12. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
[No Abstract] [Full Text] [Related]
13. Variation of alpha 2-plasmin inhibitor in patients with gastric cancer.
Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
Bull Osaka Med Sch; 1984 Oct; 30(2):89-95. PubMed ID: 6571385
[No Abstract] [Full Text] [Related]
14. Delayed elimination of fibrin from the lungs in rats given alpha 2-antiplasmin.
Carlin G; Einarsson M; Saldeen T
Thromb Haemost; 1981 Dec; 46(4):757-8. PubMed ID: 7330830
[TBL] [Abstract][Full Text] [Related]
15. Low grade intravascular coagulation in rhabdomyosarcoma (a fibrinogen kinetic study in vivo).
Goldschmidt B; Koós R
Acta Paediatr Acad Sci Hung; 1981; 22(1-2):19-24. PubMed ID: 7270132
[No Abstract] [Full Text] [Related]
16. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
17. [Meningococcemia and disseminated intravascular coagulation (DIC). Reports of 2 cases].
Nielsen G; Simonsen EE; Schmidt KG
Ugeskr Laeger; 1974 May; 136(21):1156-8. PubMed ID: 4839964
[No Abstract] [Full Text] [Related]
18. [Alpha 2-antiplasmin in childhood].
Weissbach G; Domula M; Rieske K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):161-70. PubMed ID: 6177599
[TBL] [Abstract][Full Text] [Related]
19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
